Coya Therapeutics Inc. (COYA)
NASDAQ · Healthcare
Coya Therapeutics Inc. Operating Income 2022–2025
Coya Therapeutics Inc. annual/quarterly operating income history and growth rate from 2022 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Coya Therapeutics Inc. operating income for the quarter ending March 31, 2026 was -7.6 M, a 0.48% decrease year-over-year.
- Coya Therapeutics Inc. operating income for the twelve months ending March 31, 2026 was -24.2 M, a 44.41% increase year-over-year.
- Coya Therapeutics Inc. annual operating income for 2025 was -22.6 M, a 30.76% increase from 2024.
- Coya Therapeutics Inc. annual operating income for 2024 was -17.2 M, a 118.26% increase from 2023.
- Coya Therapeutics Inc. annual operating income for 2023 was -7.9 M, a 19.45% decrease from 2022.
- Coya Therapeutics Inc. annual operating income for 2022 was -9.8 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Coya Therapeutics Inc. Operating Income — FAQ
Coya Therapeutics Inc. (COYA) operating income over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Coya Therapeutics Inc.'s operating income?
Coya Therapeutics Inc. (COYA) reported operating income of -$23M for fiscal 2025.
Where can I see COYA's operating income history?
The chart and table above show Coya Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.